BridgeMD
New treatment option for Paralytic Lagophthalmos
Official title Self-Adhering Magnetic Device to Treat Corneal Exposure
ClinicalTrials.gov ID: NCT06291818
What this study is testing
- What it's testing
- Paralytic lagophthalmos can be difficult to treat and manage. It has a host of causes and effects, one of which (for the latter) is exposure keratopathy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Males and females ages 18-80 years old.
- Patients with recent corneal abrasion and no signs of infection in the examination
- Patients with lagophthalmos
- Normal Controls
You likely can't join if
- Individuals with adhesive or tape allergies.
- Individuals with a history of metal pieces/shavings embedded in the eye (such as from welding or metalworking)
- Individuals with eye infections
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.